Cibus, Inc. (CBUS) stock
CBUSNasdaqAgricultural ChemicalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30206% above fair value
$1.39+0.19 (+15.83%)
Close on Nov 17, 2026Market cap $106.24MP/E –Yield –
Cibus r&d expenses
Research and development expenses are spending on new products and technology.
Cibus's R&D Expenses for the twelve months ending Jun 30, 2026 was $37.39M, down 24.4% year over year. For fiscal 2025 it was $44.20M, down 12.4% from the year before. Over ten years it grew 31.9% a year on average. The highest annual figure on record is $50.43M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.20M | -12.4% |
| FY2024 | Dec 31, 2024 | $50.43M | +19.0% |
| FY2023 | Dec 31, 2023 | $42.37M | +266.7% |
| FY2022 | Dec 31, 2022 | $11.55M | +1.9% |
| FY2021 | Dec 31, 2021 | $11.34M | +2.3% |
| FY2020 | Dec 31, 2020 | $11.08M | -9.3% |
| FY2019 | Dec 31, 2019 | $12.21M | +17.9% |
| FY2018 | Dec 31, 2018 | $10.36M | -10.0% |
| FY2017 | Dec 31, 2017 | $11.51M | +104.1% |
| FY2016 | Dec 31, 2016 | $5.64M | +103.8% |
| FY2015 | Dec 31, 2015 | $2.77M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.51M | -30.4% |
| Q1 FY2026 | Mar 31, 2026 | $8.72M | -26.1% |
| Q4 FY2025 | Dec 31, 2025 | $9.39M | -24.5% |
| Q3 FY2025 | Sep 30, 2025 | $10.78M | -17.0% |
| Q2 FY2025 | Jun 30, 2025 | $12.23M | -5.9% |
| Q1 FY2025 | Mar 31, 2025 | $11.80M | -1.8% |
| Q4 FY2024 | Dec 31, 2024 | $12.43M | -12.5% |
| Q3 FY2024 | Sep 30, 2024 | $12.99M | -25.9% |
| Q2 FY2024 | Jun 30, 2024 | $12.99M | +54.1% |
| Q1 FY2024 | Mar 31, 2024 | $12.01M | +443.8% |
| Q4 FY2023 | Dec 31, 2023 | $14.21M | +505.6% |
| Q3 FY2023 | Sep 30, 2023 | $17.52M | +480.9% |
| Q2 FY2023 | Jun 30, 2023 | $8.43M | +159.4% |
| Q1 FY2023 | Mar 31, 2023 | $2.21M | -24.9% |
| Q4 FY2022 | Dec 31, 2022 | $2.35M | -18.0% |
| Q3 FY2022 | Sep 30, 2022 | $3.02M | +16.9% |
| Q2 FY2022 | Jun 30, 2022 | $3.25M | +14.3% |
| Q1 FY2022 | Mar 31, 2022 | $2.94M | -3.6% |
| Q4 FY2021 | Dec 31, 2021 | $2.86M | -12.4% |
| Q3 FY2021 | Sep 30, 2021 | $2.58M | +17.0% |
| Q2 FY2021 | Jun 30, 2021 | $2.84M | +0.7% |
| Q1 FY2021 | Mar 31, 2021 | $3.05M | +9.4% |
| Q4 FY2020 | Dec 31, 2020 | $3.27M | -11.2% |
| Q3 FY2020 | Sep 30, 2020 | $2.20M | -38.4% |
| Q2 FY2020 | Jun 30, 2020 | $2.83M | +3.2% |
| Q1 FY2020 | Mar 31, 2020 | $2.79M | +25.6% |
| Q4 FY2019 | Dec 31, 2019 | $3.68M | +46.6% |
| Q3 FY2019 | Sep 30, 2019 | $3.58M | +4.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.74M | -15.5% |
| Q1 FY2019 | Mar 31, 2019 | $2.22M | +111.7% |
| Q4 FY2018 | Dec 31, 2018 | $2.51M | +6.7% |
| Q3 FY2018 | Sep 30, 2018 | $3.44M | -46.6% |
| Q2 FY2018 | Jun 30, 2018 | $3.24M | +123.1% |
| Q1 FY2018 | Mar 31, 2018 | $1.05M | -17.2% |
| Q4 FY2017 | Dec 31, 2017 | $2.35M | +36.2% |
| Q3 FY2017 | Sep 30, 2017 | $6.44M | +420.9% |
| Q2 FY2017 | Jun 30, 2017 | $1.45M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.27M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.73M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.24M | – |
See a number that looks wrong?